bloomberg good article democrats plans change drug friendly legislation might stop reforms occurring i quote industry leaders including jim greenwood president washington based biotechnology industry organization say expect house pass change medicare legislation would let federal government directly negotiate prices million elderly disabled citizens enrolled drug plan snip take votes senate consider legislation democrats majority even measure got bush would probably veto greenwood says overturning veto requires two thirds majorities chambers snip kennedy outgoing chairman committee wyoming republican senator michael enzi working bill places additional requirements companies food drug administration advertising monitoring new drugs lawmakers including north dakota senator byron dorgan push let americans buy cheaper medicines canada lawmakers also trying design process allow fda clearance first generic versions major biotech drugs generic medicines often sell third price brand name products snip looking supporting policy makers share similar philosophies access quality health care `` says pfizer spokesman jack cox greenwood johnson say groups members reaching democrats expect industry political giving shift democrats want leverage power generate pac donations wealthy industry `` tufts university berry says one hand going spank industry another hand going hold hands palms `` view pay close attention last two paragraphs dems like waxman likely bought others likely resist cash additionally though decider chief like use veto often look slap legislation disses pals drug industry may token reforms nothing meaningful likely point hat tip pharmagossip